JPMORGAN CHASE & CO SEC Filings

JPMorgan Chase & Co. General Counsel Stacey Friedman reported multiple equity transactions on January 13, 2026. Two blocks of Restricted Stock Units (RSUs) covering 15,227 and 14,215 units were converted into the same number of JPMorgan common shares at an exercise price of $0.0000 per unit.

On the same date, 15,826 common shares were disposed of at a price of $318.715 per share, leaving 50,136 common shares held directly. Additional indirect holdings total 68,757 common shares held by a GRAT and 13,604 common shares held by a trust. The RSUs referenced vest in two equal installments on January 13, 2025 and January 13, 2026 for one grant, and on January 13, 2026 and January 13, 2027 for the other.

JPMorgan Chase & Co. executive Mary E. Erdoes, CEO of Asset & Wealth Management, reported several equity transactions dated January 13, 2026. She acquired 26,446 and 23,692 shares of JPMorgan common stock at $0 per share through the vesting and settlement of restricted stock units (transaction code M), bringing her directly held common stock to 652,080 shares before tax withholding.

On the same date, 27,212 shares of common stock were disposed of at a price of $318.715 per share (transaction code F), leaving Erdoes with 624,868 directly owned JPMorgan shares after the reported transactions. The filing notes that each RSU represents a right to receive one common share, with RSU awards vesting in two equal installments on specified January 13 vesting dates in 2025, 2026, and 2027.

JPMorgan Chase & Co. Chief Information Officer Lori A. Beer reported equity award activity involving restricted stock units (RSUs) and common stock on January 13, 2026.

She converted 8,816 RSUs and 8,349 RSUs into an equal number of JPMorgan common shares at an exercise price of $0 per share. On the same date, she disposed of 8,975 shares of common stock at a price of $318.715 per share. After these transactions, she directly owned 64,546 shares of JPMorgan common stock. Each RSU represents a contingent right to receive one share of common stock, with the reported RSU awards vesting in two 50% tranches on specified January 13 vesting dates.

JPMorgan Chase & Co.'s Chief Financial Officer Jeremy Barnum reported multiple equity transactions on January 13, 2026. He acquired 12,861 shares of common stock and 12,021 shares of common stock through the exercise of Restricted Stock Units (RSUs) at a price of $0 per share. On the same date, he disposed of 13,310 shares of common stock at $318.715 per share. Following these transactions, he beneficially owned 29,589 shares of JPMorgan Chase common stock directly. Each RSU represents a contingent right to receive one share of common stock, with the reported RSU grants vesting in two equal installments across January 13, 2025, January 13, 2026, and January 13, 2027.

JPMorgan Chase & Co. executive Ashley Bacon, the Chief Risk Officer, reported equity award activity and a share sale. On January 13, 2026, Bacon converted 14,693 and 14,215 restricted stock units into common shares at a stated price of $0 per share, reflecting the settlement of previously granted RSUs.

On the same date, Bacon disposed of 14,178 shares of common stock at $318.715 per share. After these transactions, Bacon directly owned 244,521 shares of JPMorgan Chase common stock and held 14,216 restricted stock units, each representing a contingent right to receive one share, with vesting schedules extending to January 13, 2027.

JPMorgan Chase Financial Company LLC is offering auto callable contingent interest notes linked to the MerQube US Large-Cap Vol Advantage Index, fully and unconditionally guaranteed by JPMorgan Chase & Co. The notes pay a monthly contingent coupon only when the Index is at or above 70% of its initial level, and can be automatically called quarterly if the Index is at or above its initial level, with the earliest call date in July 2026.

If the notes are not called and the Index finishes below 60% of its initial level at maturity, investors lose 1% of principal for each 1% decline and can lose their entire investment. A hypothetical contingent interest rate of 14.00% per annum illustrates potential income if barriers are met. The Index embeds 6.0% per annum in daily deductions, uses leveraged exposure of up to 500% to E-mini S&P 500 futures, and may be significantly uninvested, all of which can drag performance. The indicative estimated value is about $901 per $1,000 note and will not be less than $900, reflecting selling commissions, hedging costs and issuer funding assumptions.

JPMorgan Chase Financial Company LLC is offering auto callable contingent interest notes linked to the common stock of Micron Technology, Inc., maturing January 31, 2029 and fully guaranteed by JPMorgan Chase & Co. The notes may pay a contingent interest rate of at least 19.75% per year, if on a Review Date Micron’s share price is at or above 50% of its initial level, which also serves as the interest barrier and trigger value.

The notes are automatically called, starting July 27, 2026, if Micron’s share price on a Review Date (other than the first and final) is at or above the initial value, returning $1,000 per note plus due contingent interest. If the notes are not called and Micron’s final share price is below the trigger, investors lose 1% of principal for every 1% decline from the initial value and could lose their entire investment. The preliminary estimated value is about $950 per $1,000 note and will not be less than $920, and the notes are unsecured, unsubordinated obligations with minimum denominations of $1,000.

JPMorgan Chase Financial Company LLC, fully guaranteed by JPMorgan Chase & Co., is offering $2,057,000 of Capped Dual Directional Buffered Equity Notes linked to the least performing of the Dow Jones Industrial Average, the Russell 2000 Index and the S&P 500 Index, maturing on February 19, 2027. The notes provide unleveraged exposure to index moves, with a Maximum Upside Return of 18.50% (maximum payment of $1,185 per $1,000 note) when all three indices finish above their initial levels.

If the least performing index is flat or down by up to the 15.00% buffer, investors receive a positive return equal to the absolute decline, up to a maximum of $1,150 per $1,000 note when that index is down 15%. If any index falls by more than 15%, principal is reduced 1% for each 1% loss beyond the buffer, up to an 85% loss of principal at maturity. The notes pay no interest or dividends, are unsecured obligations subject to the credit risk of JPMorgan Chase Financial Company LLC and JPMorgan Chase & Co., and are not listed on any exchange. The price to public is $1,000 per note, with selling commissions of $7.25 per $1,000 and an estimated value of $986.70 per $1,000 at pricing.

JPMorgan Chase Financial Company LLC is offering $100,000 of auto callable contingent interest notes linked to the common stock of Biogen Inc., maturing on January 19, 2028. The notes pay a contingent interest of $28.125 per $1,000 note each quarter (an annual rate of 11.25%) for any Review Date when Biogen’s closing share price is at or above the Interest Barrier of 70.00% of the Initial Value, set at $178.30 (Interest Barrier $124.81). Missed interest can be paid later if the barrier is met on a future Review Date.

The notes are automatically called, and pay back $1,000 plus due interest, if on any Review Date other than the first or final one (earliest July 13, 2026) Biogen’s price is at or above the Initial Value. If the notes are not called and Biogen’s final price is below the Trigger Value (70.00% of the Initial Value), repayment is reduced one-for-one with the stock loss, and investors can lose most or all principal. The notes are unsecured obligations of JPMorgan Chase Financial, fully and unconditionally guaranteed by JPMorgan Chase & Co., with an estimated value of $962.40 per $1,000 at pricing, and are expected to be illiquid and sensitive to issuer credit risk.